Capital World Investors
RUBY

Capital World Investors’s Rubius Therapeutics, Inc RUBY Stock Holding History

Capital World Investors’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,214,200
Closed -$1.88M – 579
2022
Q2 		$1.88M Sell
2,214,200
-536,800
-20% -$901K ﹤0.01% 523
2022
Q1 		$15.2M Hold
2,751,000
– – ﹤0.01% 507
2021
Q4 		$26.6M Buy
2,751,000
+100,000
+4% +$1.39M ﹤0.01% 510
2021
Q3 		$47.4M Buy
2,651,000
+1,200,667
+83% +$26.1M 0.01% 447
2021
Q2 		$35.4M Hold
1,450,333
– – 0.01% 485
2021
Q1 		$38.4M Buy
1,450,333
+333,333
+30% +$4.87M 0.01% 462
2020
Q4 		$8.48M Hold
1,117,000
– – ﹤0.01% 522
2020
Q3 		$5.6M Hold
1,117,000
– – ﹤0.01% 526
2020
Q2 		$6.68M Sell
1,117,000
-645,598
-37% -$3.81M ﹤0.01% 487
2020
Q1 		$7.84M Sell
1,762,598
-3,414,402
-66% -$25.4M ﹤0.01% 454
2019
Q4 		$49.2M Buy
5,177,000
+2,114,604
+69% +$20.5M 0.01% 354
2019
Q3 		$24M Hold
3,062,396
– – 0.01% 390
2019
Q2 		$48.2M Hold
3,062,396
– – 0.01% 350
2019
Q1 		$55.4M Hold
3,062,396
– – 0.01% 341
2018
Q4 		$48.1M Buy
3,062,396
+170,000
+6% +$3.1M 0.01% 348
2018
Q3 		$67.9M Buy
+2,892,396
New +$66.1M 0.02% 350

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Capital World Investors's RUBY Position: Q3 2022 in Review

Capital World Investors sold out of Rubius Therapeutics, Inc (RUBY) in Q3 2022, closing a stake of 2,214,200 shares — an estimated $1.88M sold.

Capital World Investors first reported a position in RUBY in Q3 2018 and held it in 16 quarters. The position peaked at $67.9M in Q3 2018. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

  • Capital World Investors reported no remaining Rubius Therapeutics, Inc position as of Q3 2022 after selling out during the quarter.
  • Capital World Investors sold 2,214,200 Rubius Therapeutics, Inc shares in Q3 2022, an estimated $1.88M.
  • Capital World Investors first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 16 quarters.
  • Capital World Investors's Rubius Therapeutics, Inc position peaked at $67.9M in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.